Drug intelligence / Profile preview

Crila Forte

Development stage
Unknown
Lead developer
ThienDuocPharma
Modality
Small Molecules
Administration
Oral
01

Overview

Crila Forte is a herbal medicinal product developed by ThienDuocPharma JSC, containing a 500mg dried extract of *Crinum latifolium* L. (Royal Virgin plant) per capsule, which is equivalent to 2.5mg of total alkaloids. It is indicated for the treatment of uterine fibroids in women and benign prostatic hyperplasia (BPH) in men, specifically to alleviate symptoms such as urinary difficulty and frequent nighttime urination. The bioactive alkaloids in the extract function by inhibiting the proliferation of tumor cells and reducing their nutrient uptake, ultimately inducing apoptosis. The product is manufactured in a GMP-WHO certified facility using raw materials from GACP-WHO certified plantations in Vietnam. Crila Forte is a higher-strength formulation of the original Crila product, which contains 250mg of the extract.

Brand names
Crila Forte
Other names
crila-forteCrinum latifolium L. extractTrinh nữ hoàng cung extractRoyal Virgin plant extract

Beyond the preview

Go deeper on Crila Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crila Forte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call